India lowers AstraZeneca COVID-19 vaccine price for less than Rs 200 per dose
New Delhi: The Indian government has lowered the price at which it buys AstraZeneca's COVID-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.
"The renegotiated price is significantly lower than 200 rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a news conference.
Read also: AstraZeneca COVID-19 vaccine recommended in Germany for people over 65
The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.
Next Story
